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Abstract
Backgound: The aim of this study was to evaluate the safety and practicality of very early
(within 48 h) discharge with long-term follow-up results, and to define an optimal length of
stay in hospital for patients with ST elevation myocardial infarction (STEMI) according to
their demographic characteristics and risk assessment.
Methods: A total of 267 patients with STEMI successfully treated with primary coronary inter-
vention were retrospectively analyzed. Patients was divided into four groups according to length of
hospitalization: 24 hours, 48 hours, 72 hours, and more than 72 hours. The groups were compared
in terms of the patients’ demographic and clinical characteristics, short- and long-term follow-up
results, mortality, revascularization and major adverse cardiac events (MACE).
Results: More than two thirds of the patients were discharged within 48 hours (68.9%). No
difference was observed between groups in terms of one month and one year MACE and one
year restenosis. However, one month restenosis was slightly higher in the fourth group. At the
end of the first year, there had been only four deaths, and these were in the third and fourth
groups. There were no deaths among patients discharged within 48 hours. Killip class, left
ventricular ejection fraction, multi-vessel disease and diabetes were the major determinants of
length of stay in hospital.
Conclusions: Very early discharge is safe and feasible and does not increase the mortality
rate. Uncomplicated STEMI patients with single vessel disease could be discharged after
24 hours. Patients with multi-vessel disease classified in the low risk group could be discharged
after 48 hours. (Cardiol J 2011; 18, 4: 378–384)
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Introduction
Length of stay in hospital for acute ST eleva-
tion myocardial infarction (STEMI) has gradually
shortened over the last 40 years [1]. However, there
is no clear consensus or guidelines for the optimal
length of hospital stay for patients with STEMI. The
duration changes according to individual cardiolo-
gy clinic or physician. Although average hospital
stays range from two to ten days, several recent
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studies have shown the possibility of early dis-
charge of low-risk acute myocardial infarction (MI)
patients [1–4]. In this present study, we aim to eva-
luate early and late outcomes of very early dis-
charge, so as to test the feasibility and safety of early
discharge and define an optimal length of hospital
stay according to risk assesment and clinical cha-
racteristics of STEMI patients.
Methods
Patient population
From December 2006 to September 2009,
a total of 267 consecutive patients with acute
STEMI treated by primary percutenous coronary
intervention (PCI) were included. Patients were
evaluated retrospectively and information was en-
tered into a computer database. All the patients
were followed up for a year, and their one month
and one year control examinations were inspected.
Patient selection, procedure and protocol
All the patients with acute STEMI who had
been successfully treated with primary PCI were
included in our study. A percutaneous femoral ap-
proach with a 6 French arterial sheath was used in
94% of the patients, while a transradial artery ap-
proach with a 6 French arterial sheath was used in
the other 6%. The radial artery sheath was imme-
diately removed after the procedure. The femoral
arterial sheath was removed six hours after the
procedure to allow clotting time, with manual com-
pression being performed subsequently. Heparin
120 IU/kg was administered before the primary PCI
and 0.1 U/kg enoxaparine was adninistered twice
a day for at least three days. Acetylsalicylic acid
(300 mg) was given as initial therapy and continu-
ed for one month, whereupon the dosage was low-
ered to 100 mg. Clopidogrel was given to all patients
at a 600 mg loading dose at the start of PCI and all
the patients were maintained on clopidogrel 75 mg
a day for at least two months. A drug-eluting stent
was used in only seven patients, with clopidogrel
being continued for a year in this group. Patients
who received adjunctive tirofiban therapy were gi-
ven continuous tirofiban infusion for 24 hours after
a loading dose (the loading dose was given during
PCI: 10 g/kg; maintenance dose: 0.15 g/min). Beta-
-blockers, ACE inhibitors and statins were also gi-
ven to all patients, unless contraindicated.
Patients was divided into four groups accord-
ing to length of stay in hospital: 24 hours, 48 hours,
72 hours, and more than 72 hours. Discharge with-
in 48 hours (Groups 1 and 2) was defined as very
early discharge. Group 1 patients were discharged
directly from the coronary intensive care unit. Pa-
tients from other groups were discharged from the
cardiology service. Our cardiac center has a policy
of discharging uncomplicated acute STEMI patients
within 48 hours. Although the patients were evalu-
ated retrospectively, and a definitive early discharge
protocol had not been proposed initially, more than
half of the patients were in the 24 or 48 hours groups
and our policy gives the opportunity to assess ear-
ly discharge effectively. Patients who underwent
immediate by-pass surgery were  included in the
more than 72 hours group. All the patients were fol-
lowed up by three staff cardiologists working in col-
laboration. Thus, all the patients were given
standardized medical therapy according to clinical
guidelines during the follow-up period.
Definitions
Standard 12-lead electrocardiograms were per-
formed for all patients. Acute STEMI was defined
as typical chest pain lasting more than 30 min with
ST-segment elevation > 1 mm in at least two con-
secutive precordial or inferior leads, or chest pain
with new onset of complete left bundle branch
block. Procedural success was defined as a reduc-
tion to residual stenosis of < 20% by balloon an-
gioplasty and stent procedure followed by Throm-
bolysis in Myocardial Infarction (TIMI) grade 2–3
flow in the infarct related artery (IRA). Multi-ves-
sel disease was defined as a stenosis of >50% of
two major epicardial coronary arteries. Left ventri-
cular ejection fraction was assessed by echocardio-
graphy which was performed after primary PCI in
the coronary intensive care unit. Left ventricular
ejection fraction (LVEF) was measured using Sim-
pson’s method and the Teicholtz formula with a GE
Vivid 3 echocardiograpy device. All the patients
were classified according to heart failure (HF) signs
and blood pressure as being in Killip class 1, 2, 3 or
4 on initial examination. Killip class 1 patients had
no evidence of HF; Killip class 2 patients had mild
HF with rales involving one third or less of the pos-
terior lung fields and systolic blood pressure of
90 mm Hg or higher; Killip class 3 patients had pulmo-
nary edema with rales involving more than one third
of the posterior lung fields and systolic blood pres-
sure of 90 mm Hg or more; and Killip class 4 pa-
tients had cardiogenic shock with any rales and sys-
tolic blood pressure of less than 90 mm Hg. Mor-
tality was defined as death of patient within the first
year due to cardiac etiology, and also sudden death
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of patient without contact with the healthcare sys-
tem and with possible cardiac predisposition.
Study end-points
Death, reinfarction, and revascularization of
infarct related artery were primary end-points.
Defining an optimal length of stay in hospital accord-
ing to a patient’s demographic and clinical charac-
teristics was a secondary end-point.
Outpatient care and follow-up
All patients were told to look for signs of re-
current ischemia, and seven days’ rest was suggest-
ed. Patients were advised to call the clinic immedia-
tely in case of chest pain, palpitations, dyspnea  or
any adverse symptoms. Clopidogrel therapy was
given to all patients for at least two months in whom
a bare metal stent had been implanted. All the pa-
tients also recieved acetylsalicylic acid, beta-block-
ers, ACE inhibitors and/or angiotensin receptor
blockers and statins unless absolutely contraindi-
cated. An exercise stress test was performed for
patients who defined chest pain at one month  fol-
low-up. Eventually this test was performed on 70%
of the patients at the one year control examination,
with only 10% of patients being evaluated by phone
call. The other 20% of patients were evaluated via
anamnesis and physical examination alone.
Statistical analysis and approval of study
Statistical analyses were performed using SPSS
15.0 (SPSS Inc., Chicago, IL, USA) software. De-
scriptives of the parameters are quoted as mean
± SD and 95% confidence intervals (CI). The unpaired
t-test was used for continuous variables between
groups, while continuous variables were compared
using the Student t test. The relationships between
length of hospital stay and categorical factors were
analyzed by the c2 test and Fisher’s exact test, and
Kruskal-Wallis test was used for the correlation be-
tween non-categorical variables and hospitalization
interval. In addition, binary logistic regression ana-
lysis in the multivariate analysis was performed to
detect independent factors predicting length of hos-
pital stay. The early discharged group was compared
to the other two groups in the multivariate regres-
sion analysis. Regression analysis was also per-
formed to demonstrate predictors of mortality and
major adverse cardiac events (MACE). All p values
were two-sided in tests and p values of less than 0.05
were considered to be statistically significant.
The study was approved by the Ethics Com-
mittee of our hospital.
Results
Baseline demographic and clinical characteris-
tics of patients are summarized in Table 1. The
mean age was 54.8 ± 11.3 years, ranging from
26 to 88, and 206 (86.1%) of the patients were male.
Although the great majority of patients (90.6%) had
no history of coronary heart disease, half of them
Table 1. Baseline demographic characteristics,
clinical features, length of hospital stay and
follow-up results of patients (n = 267).




Diabetes mellitus 67 (25.1%)
Hypertension 139 (52.1%)
Previous MI 25 (9.4%)
Previous stroke 1 (0.4%)
Dyslipidemia 129 (48.3%)
Current smoking 185 (69.3%)













24 hours 90 (33.7%)
48 hours 94 (35.2%)
72 hours 46 (17.2%)
> 72 hours 37 (13.9%)
Multi-vessel disease 154 (57.7%)
Pseudoaneurysm 1 (0.4%)
Acute thrombosis 1 (0.4%)
Restenosis at one month 8 (3%)
Angiography at one month 30 (11.2%)
Restenosis at one year 27 (10.1%)
Angiography at one year 47 (17.6%)
CABG related to restenosis 10 (3.7%)
Mortality 4 (1.5%)
MI — myocardial infarction; LAD — left anterior descending artery;
CX — circumflex artery; RCA — right coronary artery; DX — diagonal
artery; CABG — coronary artery by-pass graft surgery
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had hypertension and dyslipidemia and 25% had
diabetes mellitus (DM). Most of the patients were
heavy smokers, and, in parallel, most were male.
Left anterior descending artery (LAD) was the most
frequently involved vessel,followed by right coro-
nary artery (RCA) (46.1% vs 33.7%). Eighy two per
cent of the patients were classified as Killip 1 at
initial presentation and more than half of the pa-
tients had multi-vessel disease. The associations of
hospital stay time to the follow-up characteristics
of the patients are shown in Table 1. More than half
of the patients (n = 184) were discharged within
48 hours of hospitalization. Only 13.7% of patients
stayed in hospital for more than three days. There
was no significant difference in the baseline chara-
cteristics in terms of age, sex, smoking, dyslipi-
demia or previously diagnosed coronary heart dis-
ease. Females tended to have a longer stay in hos-
pital (p = 0.02). Patients with DM and hypertension
also had longer hospitalizations (p < 0.001 and
p = 0.03, respectively, Table 2).
The relationship between patients’ clinico-de-
mographic characteristics and hospital stay is shown
in Table 3. In patients with 24-hours hospital stay,
the rate of multi-vessel disease was significantly
less than that of patients with long stays in hospital
(p < 0.001).
In other words, when the rate of multi-vessel
involvement increased, the patients more frequent-
ly stayed in hospital. Regarding the infarct related
artery, LAD involvement was predominant, where-
as circumflex artery (CX) involvement was found
to be low in Group 4 patients. There was a border-
line correlation between LAD and CX involvement
and hospital stay (p = 0.05 and 0.05, respectively).
The Killip class 2-3-4 patients were clustered in
Group 4 (Table 3). A significant positive correlation
was detected between Killip class 2-3 and length of
hospital stay (p = 0.001 and p < 0.001, respective-
ly), while there was a significant negative relation-
ship between Killip class 1 and hospitalization in-
terval (p < 0.001). In patients with a 72-hours hos-
pital stay, LVEF was significantly lower than that
of patients in the other groups (p < 0.001, Table 3).
In addition, patients with longer hospital stays
tended to take tirofiban infusions more frequently.
Logistic regression analysis showed that Killip clas-
sification (p < 0.001), LVEF (p < 0.001), multi-ves-
sel disease (p = 0.002), and DM (p = 0.001) were
all independent determinants of length of hospital
stay. There was also a strong correlation between
Killip classification and LVEF (p < 0.001). All pa-
tients with Killip class 3-4, and 52% of Killip class
2 patients, had decreased LVEF (less than 45%).
In 87% of Killip class 1 patients, LVEF was found
to be more than 45%. There was no significant dif-
ference between length of hospitalization groups in
terms of first year restenosis (p > 0.05). However,
significant differences were found regarding rest-
enosis at one month (p = 0.03), with one month
restenosis higher in Groups 3 and 4 than in Groups 1
and 2.
MACE at one month and at one year were simi-
lar in all groups. Only four deaths had occurred
after one year, and they were in Group 3 (one
death) and Group 4 (three deaths). No mortality
was seen in patients discharged within 48 hours.
This difference was statistically significant (p = 0.03,
Table 4). Binary logistic regression analysis
for mortality indicated that Killip classification
(p < 0.001), LVEF (p = 0.03), hospital stay time
(p = 0.04) and age (p = 0.03) were the major prog-
nostic indicators predicting mortality (Table 5).
Multivariate binary logistic regression analysis for
Table 2. Demographic characteristics of patients according to length of hospital stay.
24 h (n = 90) 48 h (n = 94) 72 h (n = 46) > 72 h (n = 37) P
Age (years) 52.6 55.4 57.2 55.8 NS
Male 84 (93.3%) 83 (88.3%) 37 (80.4%) 26 (70.3%) NS
Female 6 (6.7%) 11 (11.7%) 9 (19.6%) 11 (29.7%) 0.02
Diabetes mellitus 9 (10%) 21 (22.3%) 15 (32.6%) 22 (59.5%) < 0.001
Hypertension 36 (40%) 47 (50%) 29 (63%) 27 (73%) 0.03
Previous MI 8 (8.9%) 10 (10.6%) 4 (8.7%) 3 (8.1%) NS
Previous stroke 0% 0% 0% 1 (2.4%) NS
Current smoking 69 (76.7%) 63 (67%) 29 (63%) 24 (64.9%) NS
Dyslipidemia 47 (52.2%) 41 (43.6%) 25 (54.3%) 16 (43.2%) NS
Family history 15 (16.7%) 15 (16%) 7 (15.2%) 8 (21.6%) NS
NS — not significant; MI — myocardial infarction
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Table 3. Clinical characteristics of patients according to length of hospital stay.
24 h (n = 90) 48 h (n = 94) 72 h (n = 46) > 72 h (n = 37) P
Infarct related artery:
LAD 34 (37.8%) 43 (45.7%) 23 (50%) 23 (62.2%) 0.05
CX 27 (30%) 16 (17%) 6 (13%) 3 (8.1%) 0.05
RCA 29 (32.2%) 33 (35.1%) 17 (37%) 11 (29.7%) NS
DX 0% 2 (2.1%) 0% 0% NS
Multi-vessel disease 35 (38.9%) 60 (63.8%) 32 (69.6%) 27 (73%) < 0.001
Elective CABG 1 (1.1%) 5 (5.3%) 2 (4.3%) 6 (16.2%) NS
Acute thrombosis 0% 0% 0% 1 (2.7%) NS
Pseudoaneurysm 0% 0% 0% 1 (2.7%) NS
Tirofiban infusion 22 (24.4%) 43 (45.7%) 30 (65.2%) 27 (73%) 0.001
Ejection fraction (%) 56.8 52.9 51.3 41.4 < 0.001
Killip classification:
1 90 (100%) 91 (96.8%) 32 (69.6%) 6 (16.2%) < 0.001
2 0% 3 (3.2%) 14 (30.4%) 17 (45.9%) 0.001
3 0% 0% 0% 13 (35.1%) < 0.001
4 0% 0% 0% 1 (2.7%) NS
LAD — left anterior descending artery; CX — circumflex artery; RCA — right coronary artery; DX — diagonal artery; CABG — coronary artery bypass
grafting; NS — not significant
Table 4. Mortality and major adverse cardiac events results of patients according to length of hospital stay.
24 h (n = 90) 48 h (n = 94) 72 h (n = 46) > 72 h (n = 37) P
One month restenosis 0% 1 (1.1%) 3 (6.5%) 4 (10.8%) 0.03
One year restenosis 3 (4.7%) 13 (16.5%) 7 (19.4%) 4 (12.5%) NS
CABG related to restenosis 1 (1.1%) 4 (4.3%) 4 (8.7%) 1 (2.7%) NS
Mortality 0% 0% 1 (2.2%) 3 (8.1%) 0.03
Control angiograpy:
One month 6 (6.7%) 13 (13.8%) 5 (10.9%) 6 (16.2%) NS
One year 11 (12.2%) 22 (23.4%) 7 (15.2%) 7 (18.9%) NS
NS — not significant; CABG — coronary artery bypass grafting
Table 5. Binary logistic regression analysis for
mortality.
Variables Odds ratio P
Age 1.029 0.034
Sex 1.081 0.777
Diabetes mellitus 1.042 0.078
Hypertension 0.501 0.083
Previous MI 0.648 0.617
Dyslipidemia 1.505 0.367
Current smoking 0.334 0.924
Family history 0.944 0.445
Killip classification 3.080 < 0.001
Ejection fraction 0.992 0.370
Infarct related artery 1.524 0.667
Hospital stay 1.496 0.049
Multi-vessel disease 1.411 0.667
p < 0.05 is regarded as significant; MI — myocardial infarction
MACE showed that hospital stay, multi-vessel
disease and Killip classification were the major
independent predictors (p < 0.001, p = 0.012 and
p = 0.01, respectively, Table 6).
Discussion
Early discharge for patients with STEMI is still
a controversial issue among physicians. There is no
clear consensus or guidelines for length of hospital
stay for acute STEMI patients. This duration varies
according to cardiology departments, even accord-
ing to physicians in the same clinic [3, 5]. Hospital
stay is still longer than ten days in some centers,
especially those performing thrombolytic therapy
[6]. Primary PCI is replacing thrombolytic therapy
for STEMI in most cardiac centers. The superiori-
ty of primary PCI to thrombolytic therapy has been
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demonstrated regarding morbidity and mortality [7,
8]. When compared to thrombolysis, primary PCI
allows both immediate revascularization and iden-
tification of additional relevant stenosis, meaning
that subsequently no further risk stratification
should be necessary, and hospital stay thereby
shortened. However, it has been observed that
length of hospital stay for patients treated with pri-
mary PCI remains similar to that for patients treat-
ed with thrombolytics [9]. Patients with STEMI
treated with primary PCI are often hospitalized for
five to seven days to allow monitoring of possible
complications [10].
In most cardiology centers, the average length
of stay in hospital is 4–5 days [11]. Although some
trials have demonstrated the safety of early dis-
charge of patients, most physicians are yet to
change their habitual management strategy. Recent
trials have shown that 20–30% of patients are dis-
charged later, as decided by their physicians, al-
though they were in fact compatible with early dis-
charge [3, 5]. Longer stays in hospital can damage
patients’ psychiatric status, besides increasing the
cost of therapy [10]. Economics are important where
a patient does not belong to a private or government-
-supported insurance system. In our study group,
17 patients had requested early discharge, although
their risk classification did not allow early discharge.
These patients were discharged on the second and
third days and their follow-up was uneventful at one
month. Therefore, physicians should consider eco-
nomic conditions when planning treatment. Espe-
cially within the last ten years, studies have been
investigating early discharge strategy, but they
have not reached a consensus with respect to opti-
mal length of hospital stay. In most studies, patients
classified as low risk have been discharged within
four days. Early discharge is defined as within four
days in such studies [2, 12]. Apart from these stu-
dies, only a few trials have looked at very early dis-
charge. Jirmar et al. [1] investigated the easibility
of next day discharge. Although they worked with
a small patient group, their results at one month
were uneventful for early discharged patients [1].
But, they were unable to follow up in the long term.
In the present study, we evaluated the safety
and practicality of very early discharge (within 48 h)
and we also defined the optimal length of hospital
stay according to the characteristics and risk strati-
fication of patients. We made risk classifications
according to physical examination, Killip class at the
initial admission, coronary angiography results,
echocardiography and 24-hour ECG monitoring.
Killip classification was found to be a strong factor
for both length of hospital stay and mortality by lo-
gistic regression analysis. All the patients dis-
charged after 24 hours were Killip class 1 and only
3.2% of patients who were Killip class 2 were dis-
charged within 48 hours. This group comprised only
three patients who wanted to be discharged earlier
for financial reasons.
Patients hospitalized more than three days
were usually in the Killip class > 1 and only 16.2%
of the patients in Group 4 were Killip class 1. The
remaining cases were Killip class 2–4 patients,
which proves the importance of Killip classification.
LVEF was another important prognostic fac-
tor for risk stratification. Post-procedure LVEF was
much lower in patients whose hospital stay exceed-
ed three days. Multi-vessel disease and the pres-
ence of DM were detected as the other important
indicators affecting length of hospital stay. Most
diabetic patients remained in hospital for three or
more days. More than half of the patients had multi-
vessel disease, but patients in Group 1 usually had
no multi-vessel disease (63%). Seventy-three per
cent of patients in Group 4 had multi-vessel disease.
Although there were small numbers of cases fea-
turing mortality and restenosis, these patients were
clustered in Groups 3 and 4, which indicates effi-
cient risk stratification. On the other hand, the pa-
tients at higher risk remained in hospital for longer
and had a worse prognosis. Thus, our results are
compatible with other trials [1, 3, 12].
Early discharged patients at low risk tended to
have a better prognosis. There was no significant
difference according to the rate of one year rest-
enosis among all groups. Nearly 70% of the patients
Table 6. Binary logistic regression analysis for
major adverse cardiac events within the first year.
Variables Odds ratio P
Age 1.044 0.179
Sex 0.299 0.332
Diabetes mellitus 1.114 0.178
Hypertension 1.186 0.313
Previous MI 0.209 0.156
Dyslipidemia 0.845 0.974
Current smoking 1.448 0.492
Family history 3.945 0.133
Killip classification 1.104 0.010
Ejection fraction 1.028 0.114
Infarct related artery 2.089 0.810
Hospital stay 1.863 < 0.001
Multi-vessel disease 2.089 0.012
p < 0.05 is regarded as significant; MI — myocardial infarction
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were discharged within 48 hours. This may be ex-
plained by the patient characteristics. In other
words, 90% of our patients had no history of coro-
nary heart disease, and 82% of them was classified
as Killip class 1. Our non-cardiac complications
(post-procedure fever, stroke, vascular complica-
tions associated with catheterization) were notica-
bly lower, something which could shorten the
length of stay in hospital. In our study, the possible
causes of the low rate of non-cardiac complications
include physicans’ experience and the closer follow-
-up and care of patients.
Limitations of the study
The major limitations of this study are the re-
latively small sample size and that the low morta-
lity rate (only four cases) may have affected the mor-
tality analysis. In addition, the retrospective nature
of our study could be considered as another signifi-
cant limitation. Change of physician could affect
length of hospital stay, especially for Group 3 pa-
tients. Only 25% of patients underwent control an-
giography, and the rate of exact restenosis could be
higher in asymptomatic single-vessel disease. More-
over, most of our patients were male, and female
patients tend to have lengthier stays in  hospital.
Conclusions
An early discharge strategy is very safe, and
physicians should consider a longer follow-up period
in AMI.
Uncomplicated patients with single-vessel di-
sease could be discharged after 24 hours. Uncom-
plicated patients with multi-vessel disease could be
discharged after 48 hours. Moreover, early dis-
charged patients should be instructed in the possi-
ble signs of complications and recurrent ischemia,
and their follow-up should be done more frequent-
ly to ensure patient compliance with medical the-
rapy. Our study indicates that Killip classification
and LVEF are two important prognostic factors pre-
dicting risk stratification. Multi-vessel disease and
the presence of DM are the other determinants of risk
stratification. However, prospective multi-center
studies with large sample sizes are needed to reach
a comprehensive consensus for physicians.
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